GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
EV/EBIT(x) | 27.36 | 47.70 | 27.69 | 8.47 | 9.60 |
What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?
Year | EV/EBIT |
---|---|
Mar2025 | 27.36 |
Mar2024 | 47.70 |
Mar2023 | 27.69 |
Mar2022 | 8.47 |
Mar2021 | 9.60 |
How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2025 | 27.36 | -42.64 | |
Mar2024 | 47.7 | 72.26 | |
Mar2023 | 27.69 | 226.92 | |
Mar2022 | 8.47 | -11.77 | |
Mar2021 | 9.6 | - |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹59,720.6 Cr | 5.5% | 2.6% | 20.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 5.5% |
2.6% |
20.1% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses